Text Size

Improving Gait in Multiple Sclerosis (MS) - Strength Training or Treadmill Walking?

This study has been completed.
Sponsor:
Collaborators:
Sør-Trøndelag University College
Helse Midt-Norge
Information provided by (Responsible Party):
St. Olavs Hospital
ClinicalTrials.gov Identifier:
NCT01074827
First received: February 23, 2010
Last updated: February 8, 2012
Last verified: February 2012
History of Changes

February 23, 2010
February 8, 2012
March 2010
April 2011   (final data collection date for primary outcome measure)
Walking ability [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01074827 on ClinicalTrials.gov Archive Site
  • Strength [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  • Work economy O2 [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  • Balance [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Improving Gait in Multiple Sclerosis (MS) - Strength Training or Treadmill Walking?
Strength Training or Treadmill Walking? A Randomized Control Study on the Effect on Gait in Multiple Sclerosis

The objective of this study is to evaluate the effect of strength training for the lower extremities and treadmill training on walking ability in persons with Multiple Sclerosis. The study is a randomized control trial with two groups and the intervention is 8 weeks of intensive strength training or treadmill walking. Primary outcome measure is walking ability, secondary outcome measures are balance, work economy and strength.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Multiple Sclerosis
Other: Strength training and treadmill training
Eight weeks of intensive strength training or treadmill training
  • Experimental: Treadmill group
    Specific gait training on treadmill
    Intervention: Other: Strength training and treadmill training
  • Experimental: Strength training group
    Eight weeks of intensive strength training
    Intervention: Other: Strength training and treadmill training
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
28
April 2011
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosed with Multiple Sclerosis,classified as relapsing remitting,or primary/secondary progressive
  • Expanded Disability Status Scale (EDSS)score of ≤ 6
  • Reduced walking ability (subjectively experienced)

Exclusion Criteria:

  • persons with a level of ataxia, clinically assessed, that would affect their ability to perform the training.
  • spasticity requiring stretching og treatment with baclofen.
  • Other, not MS-related, conditions affecting walking ability.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT01074827
09/225
No
St. Olavs Hospital
St. Olavs Hospital
  • Sør-Trøndelag University College
  • Helse Midt-Norge
Study Chair: Siri M, Brændvik St. Olavs Hospital
St. Olavs Hospital
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP